Europe Acne Medication Market Forecast to 2030 - Regional Analysis - by Therapeutic Class (Retinoids, Benzoyl Peroxide, Antibiotics, Salicylic Acid, and Others), Formulation (Topical Medication and Oral Medication), Type (Prescription Medicine and Over-the-Counter Medicine), Acne Type (Non-Inflammatory Acne and Inflammatory Acne), and Distribution Channel (Pharmacies and Drug Stores, Retail Stores, and E-Commerce)

BMIRE00030657 | Pages: 127 | Pharmaceuticals | Aug 2024 | Type: Regional | Status: Published

The Europe acne medication market was valued at US$ 1,963.08 million in 2022 and is expected to reach US$ 3,112.69 million by 2030; it is estimated to register at a CAGR of 6.0% from 2023 to 2030.

Individualized Treatment Programs Based on Cutting-Edge Technologies and Data-Driven Strategies Drive Europe Acne Medication Market

Adopting advanced technologies and data-driven approaches in the Europe acne medication market opens up new avenues for research and development. By collecting and analyzing patient data, researchers can gain valuable insights into the underlying causes of acne, identify patterns and trends in treatment responses, and discover new potential targets for therapeutic interventions. This can drive the development of novel medications, innovative treatment strategies, and more personalized skincare products tailored to the diverse needs of acne patients. By leveraging artificial intelligence (AI), machine learning algorithms, genetic testing, and other cutting-edge tools, healthcare providers can now analyze vast data to gain a better understanding of patient's unique skin conditions, genetic predispositions, lifestyle factors, and treatment responses. This personalized approach allows for the development of tailored treatment plans specifically designed to address each patient's individual needs.

In March 2021, Onegevity, a health intelligence firm and a subsidiary of Thorne HealthTech, teamed up with Unilever, one of the top manufacturers of beauty and personal care products worldwide, to enable a more personalized approach to acne intervention and treatment. The scientific collaboration is meant to investigate the potential of multi-omics, or the integration of different biological disciplines, to enable more individualized approaches to treating acne. The collaboration aims to create new diagnostic models that can unlock customized acne treatment plans by utilizing Onegevity's AI and machine learning capabilities that allow the evaluation of billions of biological characteristics affecting a person's health. Personalized treatment plans help to optimize treatment efficacy by taking into account patients' specific characteristics and factors that may influence their response to acne medication. Based on such patient-specific data, healthcare providers can prescribe treatments that are more likely to be effective for that particular individual. This improves the chances of successfully treating acne and reduces the likelihood of side effects and adverse reactions, leading to better patient outcomes and increased satisfaction. Thus, integrating advanced technologies and data-driven approaches for designing personalized treatment plans creates significant opportunities for innovation, growth, and improved patient outcomes in the Europe acne medication market.

Europe Acne Medication Market Overview

Europe ranks second in the global acne medication market. It is further anticipated to register a significant CAGR during the forecast period. The acne medication market growth in the region is ascribed to the increasing prevalence of acne and the growing presence of major players. The research-based pharmaceutical industry can play a key role in supporting the acne medication market growth in Europe and ensuring its future competitiveness in the global economy. Formel Skin, a Berlin-based business that is a pioneer in dermatology telehealth, announced the completion of a US$ 32.35 (30) million series fundraising round in January 2022. The funding was led by Singular and Heal Capital and supported by Cherry Ventures, Heartcore Capital, and Vorwerk Ventures. With this funding, the company plans to undertake the long-term development and expansion of its remote skincare platform.

Europe Acne Medication Market Revenue and Forecast to 2030 (US$ Million)

Get more information on this report :


Europe Acne Medication Market Segmentation

The Europe acne medication market is segmented based on therapeutic class, formulation, type, acne type, distribution channel, and country.

Based on therapeutic class, the Europe acne medication market is segmented into retinoids, benzoyl peroxide, antibiotics, salicylic acid, and others. The retinoids segment held the largest share in 2022.

In terms of formulation, the Europe acne medication market is bifurcated into topical medication and oral medication. The topical medication segment held a larger largest share in 2022.

By type, the Europe acne medication market is bifurcated into prescription medicine and over-the-counter medicine. The prescription medicine segment held a larger largest share in 2022.

Based on acne type, the Europe acne medication market is bifurcated into non-inflammatory acne and inflammatory acne. The inflammatory acne segment held a larger share in 2022.

In terms of distribution channel, the Europe acne medication market is segmented into pharmacies and drug stores, retail stores, and e-commerce. The pharmacies and drug stores segment held the largest share in 2022.

Based on country, the Europe acne medication market is categorized into Germany, France, the UK, Italy, Spain, and the Rest of Europe. Germany dominated the Europe acne medication market in 2022.

Sun Pharmaceutical Industries Ltd, Teva Pharmaceutical Industries Ltd, Almirall SA, Johnson & Johnson, Bausch Health Companies Inc, Galderma SA, Pfizer Inc, GSK Plc, Viatris Inc, and Pierre Fabre SA are some of the leading companies operating in the Europe acne medication market.

TABLE OF CONTENTS

 

1. Introduction

1.1 The Insight Partners Research Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Europe Acne Medication Market Landscape

4.1 PEST Analysis

4.2 Pricing Analysis of Topical and Oral Medication

4.3 Patient Population Undergoing Acne Treatment

5. Europe Acne Medication Market - Key Market Dynamics

5.1 Europe Acne Medication Market - Key Market Dynamics

5.2 Key Market Drivers

5.2.1 Increasing Prevalence of Severe Acne

5.2.2 Launch of Novel Drugs

5.3 Key Market Restraints

5.3.1 Side Effects Associated with Acne Medication

5.4 Key Market Opportunities

5.4.1 Individualized Treatment Programs Based on Cutting-Edge Technologies and Data-Driven Strategies

5.5 Future Trends

5.5.1 Upsurge in Need for Organic and Natural Treatments

5.6 Impact of Drivers and Restraints:

6. Acne Medication Market - Europe Market Analysis

7. Europe Acne Medication Market Analysis - by Therapeutic Class

7.1 Retinoids

7.1.1 Overview

7.1.2 Retinoids: Europe Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)

7.2 Benzoyl Peroxide

7.2.1 Overview

7.2.2 Benzoyl Peroxide: Europe Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)

7.3 Antibiotics

7.3.1 Overview

7.3.2 Antibiotics: Europe Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)

7.4 Salicylic Acid

7.4.1 Overview

7.4.2 Salicylic Acid: Europe Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)

7.5 Others

7.5.1 Overview

7.5.2 Others: Europe Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)

8. Europe Acne Medication Market Analysis - by Formulation

8.1 Topical Medication

8.1.1 Overview

8.1.2 Topical Medication: Europe Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)

8.2 Oral Medication

8.2.1 Overview

8.2.2 Oral Medication: Europe Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)

9. Europe Acne Medication Market Analysis - by Type

9.1 Prescription Medicine

9.1.1 Overview

9.1.2 Prescription Medicine: Europe Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)

9.2 Over-the-Counter Medicine

9.2.1 Overview

9.2.2 Over-the-Counter Medicine: Europe Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)

10. Europe Acne Medication Market Analysis - by Acne Type

10.1 Non-Inflammatory Acne

10.1.1 Overview

10.1.2 Non-Inflammatory Acne: Europe Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)

10.2 Inflammatory Acne

10.2.1 Overview

10.2.2 Inflammatory Acne: Europe Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)

11. Europe Acne Medication Market Analysis - by Distribution Channel

11.1 Pharmacies and Drug Stores

11.1.1 Overview

11.1.2 Pharmacies and Drug Stores: Europe Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)

11.2 Retail Stores

11.2.1 Overview

11.2.2 Retail Stores: Europe Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)

11.3 E-Commerce

11.3.1 Overview

11.3.2 E-Commerce: Europe Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)

12. Europe Acne Medication Market - Country Analysis

12.1 Europe

12.1.1 Europe: Acne Medication Market - Revenue and Forecast Analysis - by Country

12.1.1.1 Europe: Acne Medication Market - Revenue and Forecast Analysis - by Country

12.1.1.2 Germany

12.1.1.3 Germany: Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)

12.1.1.3.1 Germany: Acne Medication Market Breakdown, by Therapeutic Class

12.1.1.3.2 Germany: Acne Medication Market Breakdown, by Formulation

12.1.1.3.3 Germany: Acne Medication Market Breakdown, by Type

12.1.1.3.4 Germany: Acne Medication Market Breakdown, by Acne Type

12.1.1.3.5 Germany: Acne Medication Market Breakdown, by Distribution Channel

12.1.1.4 France

12.1.1.5 France: Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)

12.1.1.5.1 France: Acne Medication Market Breakdown, by Therapeutic Class

12.1.1.5.2 France: Acne Medication Market Breakdown, by Formulation

12.1.1.5.3 France: Acne Medication Market Breakdown, by Type

12.1.1.5.4 France: Acne Medication Market Breakdown, by Acne Type

12.1.1.5.5 France: Acne Medication Market Breakdown, by Distribution Channel

12.1.1.6 UK

12.1.1.7 UK: Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)

12.1.1.7.1 UK: Acne Medication Market Breakdown, by Therapeutic Class

12.1.1.7.2 UK: Acne Medication Market Breakdown, by Formulation

12.1.1.7.3 UK: Acne Medication Market Breakdown, by Type

12.1.1.7.4 UK: Acne Medication Market Breakdown, by Acne Type

12.1.1.7.5 UK: Acne Medication Market Breakdown, by Distribution Channel

12.1.1.8 Italy

12.1.1.9 Italy: Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)

12.1.1.9.1 Italy: Acne Medication Market Breakdown, by Therapeutic Class

12.1.1.9.2 Italy: Acne Medication Market Breakdown, by Formulation

12.1.1.9.3 Italy: Acne Medication Market Breakdown, by Type

12.1.1.9.4 Italy: Acne Medication Market Breakdown, by Acne Type

12.1.1.9.5 Italy: Acne Medication Market Breakdown, by Distribution Channel

12.1.1.10 Spain

12.1.1.11 Spain: Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)

12.1.1.11.1 Spain: Acne Medication Market Breakdown, by Therapeutic Class

12.1.1.11.2 Spain: Acne Medication Market Breakdown, by Formulation

12.1.1.11.3 Spain: Acne Medication Market Breakdown, by Type

12.1.1.11.4 Spain: Acne Medication Market Breakdown, by Acne Type

12.1.1.11.5 Spain: Acne Medication Market Breakdown, by Distribution Channel

12.1.1.12 Rest of Europe

12.1.1.13 Rest of Europe: Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)

12.1.1.13.1 Rest of Europe: Acne Medication Market Breakdown, by Therapeutic Class

12.1.1.13.2 Rest of Europe: Acne Medication Market Breakdown, by Formulation

12.1.1.13.3 Rest of Europe: Acne Medication Market Breakdown, by Type

12.1.1.13.4 Rest of Europe: Acne Medication Market Breakdown, by Acne Type

12.1.1.13.5 Rest of Europe: Acne Medication Market Breakdown, by Distribution Channel

13. Acne Medication Market- Industry Landscape

13.1 Overview

13.2 Growth Strategies in Acne Medication Market

13.3 Organic Growth Strategies

13.3.1 Overview

13.4 Inorganic Growth Strategies

13.4.1 Overview

13.5 Product Offered by Farmapiel vs Other Companies Acne Products

14. Company Profiles

14.1 Teva Pharmaceutical Industries Ltd

14.1.1 Key Facts

14.1.2 Business Description

14.1.3 Products and Services

14.1.4 Financial Overview

14.1.5 SWOT Analysis

14.1.6 Key Developments

14.2 Almirall SA

14.2.1 Key Facts

14.2.2 Business Description

14.2.3 Products and Services

14.2.4 Financial Overview

14.2.5 SWOT Analysis

14.2.6 Key Developments

14.3 Johnson & Johnson

14.3.1 Key Facts

14.3.2 Business Description

14.3.3 Products and Services

14.3.4 Financial Overview

14.3.5 SWOT Analysis

14.3.6 Key Developments

14.4 Sun Pharmaceutical Industries Ltd

14.4.1 Key Facts

14.4.2 Business Description

14.4.3 Products and Services

14.4.4 Financial Overview

14.4.5 SWOT Analysis

14.4.6 Key Developments

14.5 Bausch Health Companies Inc

14.5.1 Key Facts

14.5.2 Business Description

14.5.3 Products and Services

14.5.4 Financial Overview

14.5.5 SWOT Analysis

14.5.6 Key Developments

14.6 Galderma SA

14.6.1 Key Facts

14.6.2 Business Description

14.6.3 Products and Services

14.6.4 Financial Overview

14.6.5 SWOT Analysis

14.6.6 Key Developments

14.7 Pfizer Inc

14.7.1 Key Facts

14.7.2 Business Description

14.7.3 Products and Services

14.7.4 Financial Overview

14.7.5 SWOT Analysis

14.7.6 Key Developments

14.8 GSK Plc

14.8.1 Key Facts

14.8.2 Business Description

14.8.3 Products and Services

14.8.4 Financial Overview

14.8.5 SWOT Analysis

14.8.6 Key Developments

14.9 Viatris Inc

14.9.1 Key Facts

14.9.2 Business Description

14.9.3 Products and Services

14.9.4 Financial Overview

14.9.5 SWOT Analysis

14.9.6 Key Developments

14.10 Pierre Fabre SA

14.10.1 Key Facts

14.10.2 Business Description

14.10.3 Products and Services

14.10.4 Financial Overview

14.10.5 SWOT Analysis

14.10.6 Key Developments

15. Appendix

15.1 About The Insight Partners

15.2 Glossary of Terms

 

List of Tables

Table 1. Europe Acne Medication Market Segmentation

Table 2. Topical Medication

Table 3. Oral Medication

Table 4. Patient Population undergoing Acne Treatment from 2020-2023

Table 5. Europe Acne Medication Market - Revenue and Forecast to 2030 (US$ Million) - by Therapeutic Class

Table 6. Europe Acne Medication Market - Revenue and Forecast to 2030 (US$ Million) - by Formulation

Table 7. Europe Acne Medication Market - Revenue and Forecast to 2030 (US$ Million) - by Type

Table 8. Europe Acne Medication Market - Revenue and Forecast to 2030 (US$ Million) - by Acne Type

Table 9. Europe Acne Medication Market - Revenue and Forecast to 2030 (US$ Million) - by Distribution Channel

Table 10. Europe: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Country

Table 11. Germany: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Therapeutic Class

Table 12. Germany: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Formulation

Table 13. Germany: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Type

Table 14. Germany: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Acne Type

Table 15. Germany: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel

Table 16. France: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Therapeutic Class

Table 17. France: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Formulation

Table 18. France: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Type

Table 19. France: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Acne Type

Table 20. France: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel

Table 21. UK: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Therapeutic Class

Table 22. UK: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Formulation

Table 23. UK: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Type

Table 24. UK: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Acne Type

Table 25. UK: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel

Table 26. Italy: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Therapeutic Class

Table 27. Italy: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Formulation

Table 28. Italy: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Type

Table 29. Italy: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Acne Type

Table 30. Italy: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel

Table 31. Spain: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Therapeutic Class

Table 32. Spain: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Formulation

Table 33. Spain: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Type

Table 34. Spain: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Acne Type

Table 35. Spain: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel

Table 36. Rest of Europe: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Therapeutic Class

Table 37. Rest of Europe: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Formulation

Table 38. Rest of Europe: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Type

Table 39. Rest of Europe: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Acne Type

Table 40. Rest of Europe: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel

Table 41. Recent Organic Growth Strategies in Acne Medication Market

Table 42. Recent Inorganic Growth Strategies in the Acne Medication Market

Table 43. Glossary of Terms, Acne Medication Market

 

List of Figures

Figure 1. Europe Acne Medication Market Segmentation, by Country

Figure 2. PEST Analysis

Figure 3. Impact Analysis of Drivers and Restraints

Figure 4. Europe Acne Medication Market Revenue (US$ Million), 2022-2030

Figure 5. Europe Acne Medication Market Share (%) - by Therapeutic Class (2022 and 2030)

Figure 6. Retinoids: Europe Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)

Figure 7. Benzoyl Peroxide: Europe Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)

Figure 8. Antibiotics: Europe Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)

Figure 9. Salicylic Acid: Europe Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)

Figure 10. Others: Europe Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)

Figure 11. Europe Acne Medication Market Share (%) - by Formulation (2022 and 2030)

Figure 12. Topical Medication: Europe Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)

Figure 13. Oral Medication: Europe Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)

Figure 14. Europe Acne Medication Market Share (%) - by Type (2022 and 2030)

Figure 15. Prescription Medicine: Europe Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)

Figure 16. Over-the-Counter Medicine: Europe Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)

Figure 17. Europe Acne Medication Market Share (%) - by Acne Type (2022 and 2030)

Figure 18. Non-Inflammatory Acne: Europe Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)

Figure 19. Inflammatory Acne: Europe Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)

Figure 20. Europe Acne Medication Market Share (%) - by Distribution Channel (2022 and 2030)

Figure 21. Pharmacies and Drug Stores: Europe Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)

Figure 22. Retail Stores: Europe Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)

Figure 23. E-Commerce: Europe Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)

Figure 24. Europe: Acne Medication Market - Revenue and Forecast to 2030(US$ Million)

Figure 25. Europe: Acne Medication Market Breakdown, by Key Countries, 2022 and 2030 (%)

Figure 26. Germany: Acne Medication Market - Revenue and Forecast to 2030(US$ Million)

Figure 27. France: Acne Medication Market - Revenue and Forecast to 2030(US$ Million)

Figure 28. UK: Acne Medication Market - Revenue and Forecast to 2030(US$ Million)

Figure 29. Italy: Acne Medication Market - Revenue and Forecast to 2030(US$ Million)

Figure 30. Spain: Acne Medication Market - Revenue and Forecast to 2030(US$ Million)

Figure 31. Rest of Europe: Acne Medication Market - Revenue and Forecast to 2030(US$ Million)

Figure 32. Growth Strategies in Acne Medication Market

 

1. Teva Pharmaceutical Industries Ltd

2. Almirall SA

3. Johnson & Johnson

4. Sun Pharmaceutical Industries Ltd

5. Bausch Health Companies Inc

6. Galderma SA

7. Pfizer Inc

8. GSK Plc

9. Viatris Inc

10. Pierre Fabre SA

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Europe acne medication market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in Europe acne medication market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution.
Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement

Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.


Purchase Options
Single User License
$3550
$2840
Site License
$4550
$3640
Enterprise License
$5550
$4440